论文部分内容阅读
本文旨在确定血清结合珠蛋白在鉴别盆腔肿块患者良恶性中的预测价值。总共152例附件肿块患者,术前一周内作血清结合珠蛋白测定。因为急慢性感染的结合珠蛋白升高,故发烧患者或有其它感染、炎症者不纳入本研究。血清结合珠蛋白系采用Beckman免疫化学检测系统和Hallestad Quantimetric 2试剂,用等级比浊法测定。对患有卵巢癌患者进一步作腹膜腔冲洗、全腹膜内镜检查、淋巴结取样、网膜切除以及横膈等腹膜多处活检。 152例附件肿块患者,40例患有卵巢癌。其中34例为原发性卵巢癌,6例系转移性卵巢癌。原发性卵巢癌中,Ⅰ期者14例,Ⅱ期者1例,Ⅲ期者18例,Ⅳ期者1例。Ⅰ期中7例、Ⅱ、Ⅲ、Ⅳ期中2例患
This article aims to determine the predictive value of serum haptoglobin in the differential diagnosis of benign and malignant pelvic masses. A total of 152 patients with annex lumps, serum haptoglobin determination within a week before surgery. Because of acute and chronic infection of haptoglobin increased, so fever or other patients with infection, inflammation were not included in this study. Serum haptoglobin was assayed by the turbidimetric method using the Beckman Immunochemical Assay System and Hallestad Quantimetric 2 reagent. Patients with ovarian cancer further peritoneal flushing, the whole peritoneal endoscopy, lymph node sampling, resection of the omentum and peritoneal biopsy and other biopsies. 152 patients with annex lumps, 40 patients with ovarian cancer. 34 cases of primary ovarian cancer, 6 cases of metastatic ovarian cancer. Primary ovarian cancer, Ⅰ in 14 cases, Ⅱ in 1 case, Ⅲ in 18 cases, Ⅳ in 1 case. 7 cases in stage Ⅰ, 2 cases in stage Ⅱ, Ⅲ and Ⅳ